Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-09-11

FDA Approved: SOTALOL HYDROCHLORIDE — Supplemental Application (Apotex Corp.)

View source ↗

Summary

FDA approves Apotex Corp.'s supplemental application for sotalol hydrochloride, enabling a generic version of the antiarrhythmic for clinical use.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sotalol hydrochloride (sotalol hydrochloride)

Snippet

SUPPL AP for SOTALOL HYDROCHLORIDE (SOTALOL HYDROCHLORIDE)